Target intelligence / Profile preview

Conserved oligomeric Golgi complex subunit 6 (COG6)

Target
COG6
Molecular classification
Other (Vesicular trafficking complex subunit)
01

Overview

Conserved oligomeric Golgi complex subunit 6 (COG6) is one of eight essential protein components of the COG complex, a cytosolic vesicular tethering complex that is critical for maintaining normal Golgi apparatus morphology and the proper trafficking of proteins through the Golgi compartment[3][4][5][7]. COG6 is required for the tethering and fusion of vesicles, especially those involved in retrograde trafficking, enabling the correct localization of glycosylation enzymes and other resident Golgi proteins[1][2][5]. Loss of function or mutations in COG6 disrupt both N- and O-linked glycosylation of proteins, mislocalize Golgi enzymes, cause fragmentation of the Golgi, and lead to a rare inherited disease known as COG6-congenital disorder of glycosylation (COG6-CDG or CDG2L), characterized by developmental delay, growth abnormalities, and multisystem symptoms[1][2][4][5]. COG6 also directly interacts with a subset of Golgi SNARE proteins (such as STX5, STX6, GS27, and SNAP29), which are essential for vesicular docking and fusion events within the Golgi[2]. To date, there are no known therapeutic drugs that directly target COG6, and no evidence it serves as a direct therapeutic target.

Other names
Component of oligomeric Golgi complex 6COG complex subunit 6KIAA1134COD2CDG2LSHNScomplexed with Dor1p 2conserved oligomeric Golgi complex protein 6testicular tissue protein Li 41
02

Biological functions

Vesicular transportMaintenance of Golgi morphologyProtein glycosylationRetrograde trafficking within the Golgi
03

Disease associations

Congenital disorders of glycosylation (specifically COG6-CDG, also known as CDG2L)Developmental disorders
04

Safety considerations

Disruption causes severe developmental disorders and glycosylation defects[1][2].Mutations lead to multisystem disease (COG6-CDG), affecting development, growth, and multiple organs[1].

Beyond the preview

Go deeper on Conserved oligomeric Golgi complex subunit 6 (COG6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Conserved oligomeric Golgi complex subunit 6 (COG6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call